LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
Nevada NV
Legislatures
2025 Regular Session
Senate
Bills
SJR10
NV
Nevada Senate Bill SJR10
Nevada 2025 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
NV
Nevada 2025 Regular Session
Nevada Senate Bill SJR10
Introduced
2/26/25
Refer
2/26/25
Report Pass
4/17/25
Engrossed
4/24/25
Refer
4/24/25
Report Pass
5/14/25
Enrolled
6/1/25
Passed
6/1/25
Caption
Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds. (BDR R-801)
Latest NV SJR10 Activity
View All Events: NV 2025 Regular Session SJR10
Companion Bills
No companion bills found.
Previously Filed As
NV HB4014
Relating to a study on the use of psychedelic therapies in the treatment of certain conditions.
NV SB3005
Relating to a study on the use of psychedelic therapies in the treatment of certain conditions.
NV SB43
Provides relative to psychedelic-assisted therapy. (8/1/26) (REF INCREASE GF EX See Note)
NV SB1042
Relating To Mental Health.
NV SB3199
Relating To Mental Health.
NV SB1042
Relating To Mental Health.
NV H4986
Relative to therapeutic psilocybin treatment centers
NV SB4220
Veterans Health Administration Novel Therapeutics Preparedness Act
NV SB00191
An Act Concerning The Psychedelic-assisted Therapy Pilot Program.
NV H4200
Authorizing a pilot for the use of psychedelics in licensed treatment facilities
Similar Bills
MD SB336
Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership
MD HB427
Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership
TX HB4014
Relating to a study on the use of psychedelic therapies in the treatment of certain conditions.
AZ SB1555
Approved medication; rescheduling; controlled substance
TX SB3005
Relating to a study on the use of psychedelic therapies in the treatment of certain conditions.
GA HB717
Medical Practice Act; regulation of the administration of psychedelic-assisted treatment and therapy; provide
NJ A1526
Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million.
MA H4200
Authorizing a pilot for the use of psychedelics in licensed treatment facilities